Skip to main content
OSTEOPORE LIMITED logo

OSTEOPORE LIMITED — Investor Relations & Filings

Ticker · OSX ISIN · AU0000053324 ASX Manufacturing
Open in API
Filings indexed 488 across all filing types
Latest filing 2022-04-06 AGM Information
Country AU Australia
Listing ASX OSX

About OSTEOPORE LIMITED

https://osteopore.com

Osteopore Limited specializes in the design and manufacture of 3D-printed bioresorbable implants. The company utilizes a patented 3D printing process to create scaffolds from bioresorbable polymers, such as polycaprolactone, designed to mimic the natural microstructure of bone. These implants, including the Osteoplug, Osteomesh, and Osteostrip product lines, are applied in neurosurgical, craniofacial, and orthopedic procedures to facilitate bone healing and tissue regeneration. The scaffolds provide a temporary structural framework that supports the body's natural healing process before being gradually absorbed and replaced by the patient's own bone tissue. This technology aims to reduce long-term complications associated with permanent foreign implants by promoting natural tissue integration and restoration across various clinical applications.

Recent filings

Filing Released Lang Actions
Annual General Meeting Date 1 page 217.1KB
AGM Information Classification · 95% confidence The document is an ASX release announcing the date of the Annual General Meeting (AGM) for Osteopore Limited, including details about the meeting date, director nominations, and COVID-19 measures. It does not contain the AGM materials or presentations themselves, nor does it include financial data or voting results. The document is short (2012 characters) and serves as an announcement of the AGM date and related procedural information. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or announcements related to the AGM itself. Given the content and length, the classification is AGM Information (AGM-R) with high confidence.
2022-04-06 English
Annual Report to shareholders 66 pages 1.0MB
Annual Report Classification · 100% confidence The document is titled 'Consolidated Annual Report For the year ended 31 December 2021' and contains detailed sections typical of an annual report, including a letter from the chairman, directors' report, auditor's independence declaration, consolidated financial statements, notes to the financial statements, directors' declaration, and independent auditor's report. The content includes comprehensive financial data, operational review, corporate governance information, and auditor's report, all consistent with a full annual report. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2021
2022-03-30 English
Appendix 4G and Corporate Governance Statement 21 pages 438.4KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a form used by Australian Securities Exchange (ASX) listed entities to confirm compliance with corporate governance disclosure requirements. The document includes a checklist of governance principles and recommendations, indicating which have been followed and where disclosures can be found, often pointing to the corporate governance statement on the company's website or annual report. It is not the corporate governance statement itself, nor a full annual report, but a regulatory filing that accompanies the annual report to verify governance disclosures. The document length is 15,000 characters, but it is a structured compliance form rather than a financial or management report. This fits the definition of a Regulatory Filing (RNS) as it is a general regulatory announcement and compliance document that does not fit into other specific categories like Annual Report or Governance Information. Therefore, the correct classification is Regulatory Filings (RNS).
2022-03-30 English
SHG: & CSIRO AI Tool to Optimise Cranial Implant Procedures 4 pages 342.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Singular Health Group Ltd detailing the completion of a collaborative AI cranial implant project with CSIRO and Osteopore. It discusses the development, testing, and future validation plans of the AI model integrated into their software. The content focuses on technological and clinical progress, collaboration details, and future regulatory submission plans. There are no financial statements, earnings data, management discussions of financial results, or regulatory certifications. The document is a corporate announcement about a project completion and collaboration, not a financial report, audit, or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is an announcement of a project milestone and collaboration progress, which aligns best with a general Regulatory Filings (RNS) category as a miscellaneous corporate announcement that does not fit other specific categories.
2022-03-13 English
OSX Commences AI-Powered Design Study for Cranial Implants 3 pages 251.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX release announcing the commencement of a study between Osteopore Limited and Singular Health Group Ltd to improve cranial implant design using AI technology. It discusses the study's objectives, expected outcomes, and strategic significance. There are no financial statements, regulatory certifications, voting results, or management changes. The document is a corporate announcement about a new study and collaboration, not a financial report, earnings release, or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is a general company update about a new project, which aligns best with Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2022-03-13 English
Appendix 4E Preliminary Final Report 12 pages 212.3KB
Annual Report Classification · 100% confidence The document is titled 'Osteopore Limited and Its Controlled Entities Appendix 4E For the year ended 31 December 2021' and contains detailed financial statements including consolidated statements of profit or loss, financial position, changes in equity, and cash flows for the full fiscal year ended 31 December 2021. It includes notes to the preliminary financial statements, segment reporting, and accounting policies. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of comprehensive financial data and analysis for the full year, along with the reference to Appendix 4E (a common Australian Securities Exchange form for preliminary final reports), confirms this is a full annual financial report. Therefore, the document fits the definition of an Annual Report (10-K equivalent). FY 2021
2022-02-27 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.